156 related articles for article (PubMed ID: 30252041)
1. Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers.
Głodzik D; Purdie C; Rye IH; Simpson PT; Staaf J; Span PN; Russnes HG; Nik-Zainal S
Ann Oncol; 2018 Nov; 29(11):2223-2231. PubMed ID: 30252041
[TBL] [Abstract][Full Text] [Related]
2. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
[TBL] [Abstract][Full Text] [Related]
3. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Bautista S; Theillet C
Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
[TBL] [Abstract][Full Text] [Related]
4. ERα-associated translocations underlie oncogene amplifications in breast cancer.
Lee JJ; Jung YL; Cheong TC; Espejo Valle-Inclan J; Chu C; Gulhan DC; Ljungström V; Jin H; Viswanadham VV; Watson EV; Cortés-Ciriano I; Elledge SJ; Chiarle R; Pellman D; Park PJ
Nature; 2023 Jun; 618(7967):1024-1032. PubMed ID: 37198482
[TBL] [Abstract][Full Text] [Related]
5. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
[TBL] [Abstract][Full Text] [Related]
6. CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer.
Aleksakhina SN; Kramchaninov MM; Mikushina AD; Kubrina SE; Petkau VV; Ivantsov AO; Moiseyenko VM; Imyanitov EN; Iyevleva AG
Clin Transl Oncol; 2021 Apr; 23(4):874-881. PubMed ID: 32880048
[TBL] [Abstract][Full Text] [Related]
7. Detection of CCND1 , C-MYC , and FGFR1 amplification using modified SYBR Green qPCR and FISH in breast cancer.
Azarnezhad A; Tabrizi M; Javan F; Mehdipour P
Turk J Med Sci; 2018 Aug; 48(4):759-767. PubMed ID: 30119151
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
[TBL] [Abstract][Full Text] [Related]
9. Chromothripsis in Human Breast Cancer.
Bolkestein M; Wong JKL; Thewes V; Körber V; Hlevnjak M; Elgaafary S; Schulze M; Kommoss FKF; Sinn HP; Anzeneder T; Hirsch S; Devens F; Schröter P; Höfer T; Schneeweiss A; Lichter P; Zapatka M; Ernst A
Cancer Res; 2020 Nov; 80(22):4918-4931. PubMed ID: 32973084
[TBL] [Abstract][Full Text] [Related]
10. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
11. Tissue aluminum concentration does not affect the genomic stability of ERBB2, C-MYC, and CCND1 genes in breast cancer.
Rodrigues-Peres RM; Cadore S; Febraio S; Heinrich JK; Serra KP; Derchain SF; Vassallo J; Sarian LO
Biol Trace Elem Res; 2013 Sep; 154(3):345-51. PubMed ID: 23861098
[TBL] [Abstract][Full Text] [Related]
12. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
13. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
Cuny M; Kramar A; Courjal F; Johannsdottir V; Iacopetta B; Fontaine H; Grenier J; Culine S; Theillet C
Cancer Res; 2000 Feb; 60(4):1077-83. PubMed ID: 10706127
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
[TBL] [Abstract][Full Text] [Related]
15. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
16. Engineering targeted chromosomal amplifications in human breast epithelial cells.
Springer S; Yi KH; Park J; Rajpurohit A; Price AJ; Lauring J
Breast Cancer Res Treat; 2015 Jul; 152(2):313-21. PubMed ID: 26099605
[TBL] [Abstract][Full Text] [Related]
17. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
18. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
19. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma.
Jang M; Kim E; Choi Y; Lee H; Kim Y; Kim J; Kang E; Kim SW; Kim I; Park S
Breast Cancer Res; 2012 Aug; 14(4):R115. PubMed ID: 22863309
[TBL] [Abstract][Full Text] [Related]
20. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Choschzick M; Lassen P; Lebeau A; Marx AH; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Izbicki J; Sauter G; Simon R
Mod Pathol; 2010 Apr; 23(4):603-10. PubMed ID: 20139910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
